Patent Case Watch

Patent opinions from the Eastern District of Texas and the U.S. Court of Appeals for the Federal Circuit

E.D. Tex.

Sanofi-Aventis Deutschland GmbH v. Novo Nordisk Inc, No. 9:09-cv-00009 (E.D. Tex. Apr. 3, 2009)

Granted in Part
Venue / Transfer Motion to Dismiss
Court
U.S. District Court for the Eastern District of Texas, Lufkin Division
Case No.
No. 9:09-cv-00009, Dkt. No. 33
Decided
April 3, 2009
Judge
Ron Clark, J.
Document
Order
Docket Entry
ORDER granting in part 8 Defendant Novo Nordisk, Inc.s Motion to Dismiss,Stay, or Transfer Venue. This case will be STAYED pending resolution of the jurisdictional and licensing agreement issues by the Southern District of New York
Length
16 pages

From the Opinion

The passage below is extracted verbatim from the opening of the document. It has not been editorially summarized — consult the full opinion for the court's complete reasoning.

GRANTING IN PART DEFENDANT’S MOTION TO DISMISS, STAY, OR TRANSFER Plaintiff Sanofi-Aventis Deutschland GmbH (“Sanofi”) filed suit against Defendant Novo Nordisk, Inc. (“Novo”) claiming that Novo’s disposable injection needle with an automatic safety lock infringes United States Patent No. 6,203,529. The ‘529 patent is directed toward a needle assembly for injection devices.

Download Opinion (PDF)

Source: govinfo.gov USCOURTS collection · retrieved July 23, 2026 · Report an error